Oligomerization of hepatitis delta antigen
US6844171B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 1, 1999 |
| Grant date | Jan 18, 2005 |
| Priority date | — |
| Expiry date | Jul 1, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/10122
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention relates to HDAg peptides, including mutants, derivatives fragments and fusion molecules, including fusion proteins, coiled-coil oligomers, nucleic acid molecules, vectors comprising HDAg nucleic acid molecules, cells comprising said molecules, methods of multivalent expression and association of binding moieties of HDAg fusion molecules, and methods of use involving the molecules.The molecules are particularly useful as a framework for multivalent display via formation of C-terminal and/or N-terminal fusion proteins or via chemical coupling to chemically reactive sidechains, e.g. cysteine residues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.